ENA Respiratory has begun dosing participants in Part B of [...]

AI and Robust Scientific Foundations to Optimize Clinical Trial Operations [...]

Karyopharm Therapeutics has submitted an application to the FDA seeking [...]

Early Phase 1b data show five objective responses among six [...]

The US Food and Drug Administration (FDA) has approved Mimrylo [...]

A systematic review of more than two decades of clinical [...]

ViiV Healthcare has received US FDA approval for Tivicay PD [...]

AstraZeneca and Amgen’s Tezspire has met both co-primary and key [...]

The US FDA has approved Revolution Medicines’ daraxonrasib for adults [...]

Biogen’s felzartamab has been approved in China as a treatment [...]